This test is most useful if any of these apply to you.
When someone becomes agitated, paranoid, or confused, a urine PCP screen can help investigate possible phencyclidine exposure. Even a confirmed positive cannot establish that the drug caused the symptoms or that the person is currently intoxicated. The result needs to be interpreted with the examination, exposure history, and other possible causes.
This is an established screening test with a positive-or-negative result. Its main limitation is that some medicines and related drugs can produce a positive even when PCP is absent. A negative can also miss exposure because of timing, a small amount of drug in the urine, or sample dilution.
PCP was developed as an anesthetic and is now used illicitly for its mind-altering effects. It can make you feel detached from your body and surroundings. The urine screen targets PCP itself, including drug that leaves your body unchanged after exposure.
The screen uses an immunoassay. Lab-made antibodies react with PCP, but they can also react with certain other molecules. A positive is therefore presumptive: it is an initial finding that needs confirmation before exposure is considered established.
Confirmation uses gas or liquid chromatography with mass spectrometry. These methods separate compounds and identify PCP from its chemical characteristics. Confirmation is more specific than an antibody screen, though a PCP-only confirmation does not test for every drug that might have caused a positive screen.
PCP dissolves in fat and spreads into body tissues. Its gradual return to the bloodstream can prolong elimination after repeated use. Human dosing studies show that the body clears most PCP by breaking it down; a smaller share leaves unchanged in urine.
A urine result reflects drug excretion over a period after exposure. It cannot reliably establish the dose, the exact time of use, or the degree of impairment. Detection can outlast the main drug effects, particularly after repeated use.
The proportion of positive screens that fail confirmation varies substantially across settings. In one national reference-laboratory study, none of the positive PCP screens confirmed. In a separate emergency department study, most did confirm. The first finding does not mean that every PCP screen is unreliable. The assay and how common PCP exposure is in the tested population both affect the chance that a positive represents true exposure.
Different immunoassays have different cross-reactions. Taking a medicine on an interference list does not prove it caused your result, and a negative screen at one laboratory cannot guarantee a negative at another. Blood and urine also have different detection windows, so a negative blood test cannot automatically disprove a positive urine result.
Human poisoning reports describe agitation, paranoia, hallucinations, disorientation, and involuntary jerking of the eyes. Severe poisoning can involve dangerously high blood pressure, overheating, seizures, muscle rigidity, coma, breathing problems, and death. These are possible effects of poisoning, not predictions from a positive urine screen.
Severe muscle activity and overheating can damage muscle tissue. Rhabdomyolysis is extensive muscle breakdown that can injure the kidneys. This complication has been documented in people with PCP poisoning, but a positive screen alone does not show that it has occurred.
Studies of injured people and people undergoing alcohol withdrawal have examined whether PCP-positive urine screens predict a more difficult hospital course. Their findings differ.
| Who Was Studied | What Was Compared | What They Found |
|---|---|---|
| 10,166 trauma patients, including 130 with PCP-positive screens | PCP-positive versus PCP-negative results, with adjustment for several patient and injury characteristics | PCP positivity was associated with higher odds of death. The observational design cannot establish that PCP caused the difference. |
| 156 PCP-positive trauma patients and comparison groups | PCP-positive patients versus groups with no detected drugs or alcohol, or with other detected substances | No significant difference in mortality or length of stay. Intensive care admission was lower in the PCP-positive group than in the other-substance group. |
| 3,731 people treated for alcohol withdrawal | PCP-positive versus PCP-negative screens | 2.4% screened positive. PCP positivity was associated with cannabis, barbiturate, and cocaine positivity, but not significantly with length of stay or readmission. |
The trauma studies do not establish a consistent mortality effect. Differences in populations, co-exposures, and study methods may contribute to their different findings. These studies used screening results, which can misclassify exposure, and none makes a positive urine screen a measure of poisoning severity.
3-MeO-PCP and 4-MeO-PCP are different drugs with structures related to PCP. Human case series using specific blood and urine analyses have documented poisoning involving these compounds. Their effects can resemble PCP poisoning, and other drugs were often detected in the same cases.
Experiments with drug-spiked urine and urine from people with 3-MeO-PCP poisoning found that these compounds can trigger commercial PCP screens. The amount of cross-reaction differed between assays. This is interference with a PCP test, not proof that PCP itself is present.
Ketamine is another related drug, but the PCP immunoassays evaluated in that study did not detect it. A negative PCP screen cannot exclude ketamine or all newer dissociative drugs. Specific testing must include the suspected compound; routine PCP confirmation does not automatically identify it.
Evidence-backed interventions that affect your PCP level
Phencyclidine Screen is best interpreted alongside these tests.
Phencyclidine Screen is included in these pre-built panels.
See at once whether twelve common drugs have been used recently, from a single urine sample you can order yourself.